Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission - mortality and therapeutic efficacy

Author： Dajas-Bailador F.A.   Asencio M.   Bonilla C.   Scorza M.C.   Echeverry C.   Reyes-Parada M.   Silveira R.   Protais P.   Russell G.   Cassels B.K.   Dajas F.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.32, Iss.3, 1999-03, pp. : 373-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 8, 2015-03 ,pp. : 975-988

Bentham Science Publishers

Access to resources Recommend Favorite

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter

By Gordon I.   Weizman R.   Rehavi M.  

European Journal of Pharmacology, Vol. 298, Iss. 1, 1996-02 ,pp. : 27-30

Elsevier

Access to resources Recommend Favorite

Effects of dopaminergic agents on antinociception in formalin test - biochemistry, physiology and pharmacology

By Zarrindast M.-R.   Nassiri-Rad S.   Pazouki M.  

General Pharmacology, Vol. 32, Iss. 4, 1999-04 ,pp. : 517-522

Elsevier

Access to resources Recommend Favorite

Nomegestrol Acetate: Pharmacology, Safety Profile and Therapeutic Efficacy

By Lello Stefano  

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 541-559

Adis International

Access to resources Recommend Favorite

Chemoprotectants: A Review of their Clinical Pharmacology and Therapeutic Efficacy

By Links M.   Lewis C.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 293-308

Adis International

Access to resources Recommend Favorite